Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma
Authors:
- Klara HorackovaKHKlara Horackova
- Sona FrankovaSFSona Frankova
- Petra ZemankovaPZPetra Zemankova
- Petr NehasilPNPetr Nehasil
- Marta CernaMCMarta Cerna
- Magdalena NeroldovaMNMagdalena Neroldova
- Barbora OtahalovaBOBarbora Otahalova
- Jan KralJKJan Kral
- Milena HovhannisyanMHMilena Hovhannisyan
- Viktor StraneckyVSViktor Stranecky
- Tomas ZimaTZTomas Zima
- Marketa SafarikovaMSMarketa Safarikova
Open Access
Abstract
Hepatocellular carcinoma (HCC) mainly stems from liver cirrhosis and its genetic predisposition is believed to be rare. However, two recent studies describe pathogenic/likely pathogenic germline variants (PV) in cancer-predisposition genes (CPG). As the risk of de novo tumors might be increased in PV carriers, especially in immunosuppressed patients after a liver transplantation, we analyzed the prevalence of germline CPG variants in HCC patients considered for liver transplantation. Using the panel NGS targeting 226 CPGs, we analyzed germline DNA from 334 Czech HCC patients and 1662 population-matched controls. We identified 48 PVs in 35 genes in 47/334 patients (14.1%). However, only 7/334 (2.1%) patients carried a PV in an established CPG (PMS2, 4×NBN, FH or RET). Only the PV carriers in two MRN complex genes (NBN and RAD50) were significantly more frequent among patients over controls. We found no differences in clinicopathological characteristics between carriers and non-carriers. Our study indicated that the genetic component of HCC is rare. The HCC diagnosis itself does not meet criteria for routine germline CPG genetic testing. However, a low proportion of PV carriers may benefit from a tailored follow-up or targeted therapy and germline testing could be considered in liver transplant recipients.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (NU20-03-00285, NU20-03-00283, RVO-VFN 00064165, RVO-IKEM 00023001, COOPERATIO, SVV260516, LX22NPO05102)
- Univerzita Karlova v Praze (NU20-03-00285, NU20-03-00283, RVO-VFN 00064165, RVO-IKEM 00023001, COOPERATIO, SVV260516, LX22NPO05102)
- Ministerstvo Školství, Mládeže a Tělovýchovy (NU20-03-00285, NU20-03-00283, RVO-VFN 00064165, RVO-IKEM 00023001, COOPERATIO, SVV260516, LX22NPO05102)
This publication has 45 references indexed in Scilit:
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysisAmerican Journal of Gastroenterology, 2014
- Determining eligibility for and preparation to kidney transplantation of a patient with Lynch syndrome – a case report and literature reviewAnnals of Transplantation, 2014
- Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant dataHepatology, 2013
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic FibrosisJAMA, 2012
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEffFly, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsBioinformatics, 2009
- The natural history of compensated cirrhosis due to hepatitis C virusHepatology, 2006
- Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populationsEuropean Journal of Human Genetics, 2000
- Genetic Aspects of Hepatocellular CarcinogenesisSeminars in Liver Disease, 1999